For all media enquiries please email us on media@melanoma.org.au
Olympians join forces for melanoma warning
Jana Pittman and Melinda Gainsford-Taylor back our Game On Mole campaign, in support of their much loved coach.
MIA research wins Cancer Institute of NSW ‘Wildfire Highly Cited Publication’
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Prof Scolyer receives UTAS Alumni Award
The 'Distinguished Alumni Award' from University of Tasmania honours the exceptional impact of his work around the world.
Medical Directors receive USYD VC’s Award
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.
Aussies urged to mark start of summer by checking their skin
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment.
Prof Georgina Long awarded 2021 Ramaciotti Medal
The award recognises her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Peter Overton our new MIA National Ambassador
MIA is proud to announce that the Nine Network’s newsreader and journalist Peter Overton AM has joined us as a National Ambassador.
Promising Futures: AMC2021 conference wrap-up
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
MIA researchers on Highly Cited 2021 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Skin surveillance saves lives from melanoma
New research shows routine skin checks by a health professional, plus checking your own skin, are vital in saving lives from melanoma.
Game On Mole – saving lives this summer
COVID lockdowns may have deterred patients seeking medical treatment, making our 'Game On Mole' campaign more important than ever.
A paradigm shift in melanoma treatment
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
Akeem Alade says:
Yisa says:
Portia says: